|
Market Closed -
Sao Paulo
20:45:54 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 136.35 BRL | -4.23% |
|
-5.40% | -19.16% |
| 10-02 | AbbVie joins US government pilot to test drug discount rebates | RE |
| 10-02 | Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion | DJ |
| Market Cap | 244B 1,275B 216B 202B 184B 347B 23,416B 350B 2,444B 947B 11,970B 915B 895B 38,417B | P/E 2026 * |
20x | P/E 2027 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 263B 1,378B 234B 218B 199B 375B 25,309B 379B 2,642B 1,024B 12,938B 988B 967B 41,523B | EV / Sales 2026 * |
4.17x | EV / Sales 2027 * | 3.81x |
| Free-Float |
96.62% | Yield 2026 * |
2.13% | Yield 2027 * | 2.26% |
Last Transcript: AstraZeneca PLC
| 1 day | -4.23% | ||
| 1 week | -5.40% | ||
| Current month | -2.67% | ||
| 1 month | -1.15% | ||
| 3 months | -19.34% | ||
| 6 months | -21.80% | ||
| Current year | -19.16% |
| 1 week | 136 |  | 145.94 |
| 1 month | 133.7 | | 148.93 |
| Current year | 130.06 | | 190.4 |
| 1 year | 130.06 | | 190.4 |
| 3 years | 101.6 | | 190.4 |
| 5 years | 93.74 | | 190.4 |
| 10 years | 93.74 | | 190.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 30/09/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 31/07/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 05/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 30/09/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 26/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.23% | -5.40% | - | - | 244B | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.63% | -3.39% | +27.17% | +57.15% | 410.8B | |
| Weighted average by Cap. | +0.13% | -3.33% | +30.52% | +68.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.17B 331B 56.13B 52.39B 47.75B 90.05B 6,073B 90.89B 634B 246B 3,105B 237B 232B 9,964B | 67.01B 351B 59.54B 55.57B 50.65B 95.52B 6,442B 96.41B 672B 261B 3,293B 252B 246B 10,569B |
| Net income | 12.04B 63.04B 10.7B 9.99B 9.1B 17.17B 1,158B 17.33B 121B 46.84B 592B 45.22B 44.24B 1,900B | 13.77B 72.09B 12.24B 11.42B 10.41B 19.63B 1,324B 19.82B 138B 53.56B 677B 51.71B 50.59B 2,172B |
| Net Debt | 19.69B 103B 17.5B 16.33B 14.89B 28.07B 1,893B 28.34B 198B 76.59B 968B 73.94B 72.34B 3,106B | 11.93B 62.45B 10.6B 9.89B 9.02B 17.01B 1,147B 17.17B 120B 46.4B 586B 44.79B 43.82B 1,882B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | R$136.35 | -1.10% | 3,674 |
| 01/10/26 | R$137.87 | -1.58% | 346 |
| 30/09/26 | R$140.09 | -1.83% | 113 |
| 29/09/26 | R$142.70 | -1.24% | 111 |
| 28/09/26 | R$144.49 | +0.24% | 261 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- A1ZN34 Stock
Select your edition
All financial news and data tailored to specific country editions
